| Neuroprotective agents | 8802 | Neuroprotektive Substanz |
| 2009 1 | The neurotrophic and neuroprotective effects of psychotropic agents. [19877500] Dialogues Clin Neurosci 11(3):333-48 (2009) |
| 2007 2 | Neuroprotective effects of propofol in acute cerebral injury. [17894649] CNS Drug Rev 13(3):333-51 (2007) |
| 2007 3 | Pharmacological properties of BN82451: a novel multitargeting neuroprotective agent. [17894648] CNS Drug Rev 13(3):317-32 (2007) |
| 2001 4 | Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor. [11474423] CNS Drug Rev 7(2):172-98 (2001) |
| 2007 5 | Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. [17047683] J Cereb Blood Flow Metab 27(6):1108-28 (2007) |
| 2002 6 | Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. [11973422] J Cereb Blood Flow Metab 22(5):503-14 (2002) |
| 2001 7 | Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. [11524608] J Cereb Blood Flow Metab 21(9):1013-33 (2001) |
| 2000 8 | Estrogen as a neuroprotectant in stroke. [10779008] J Cereb Blood Flow Metab 20(4):631-52 (2000) |
| 2009 9 | Neuroprotective role of mitochondrial uncoupling protein 2 in cerebral stroke. [19240738] J Cereb Blood Flow Metab 29(6):1069-78 (2009) |
| 2003 10 | Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review. [14715440] Neurotox Res 5(6):375-83 (2003) |
| 1990 11 | Brain protection: physiological and pharmacological considerations. Part II: The pharmacology of brain protection. [2225293] Can J Anaesth 37(7):762-77 (1990) |
| 2006 12 | Triflusal: an antiplatelet drug with a neuroprotective effect? [16939630] Cardiovasc Drug Rev 24(1):11-24 (2006) |
| 2008 13 | Progesterone for the treatment of experimental brain injury; a systematic review. [17715141] Brain 131(Pt 2):318-28 (2008) |
| 2002 14 | Neuroprotective effects of antidepressant and mood stabilizing drugs. [11836978] J Psychiatry Neurosci 27(1):8-9 (2002) |
| 2004 15 | Neuroprotection and acute spinal cord injury: a reappraisal. [15717009] NeuroRx 1(1):80-100 (2004) |
| 2004 16 | Critical appraisal of neuroprotection trials in head injury: what have we learned? [15717008] NeuroRx 1(1):71-9 (2004) |
| 2004 17 | Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. [15717003] NeuroRx 1(1):5-16 (2004) |
| 2009 18 | Current status of neuroprotection for cerebral ischemia: synoptic overview. [19064810] Stroke 40(3 Suppl):S111-4 (2009) |
| 2001 19 | Neuronal cell death in nervous system development, disease, and injury (Review). [11295106] Int J Mol Med 7(5):455-78 (2001) |
| 2010 20 | Novel neuroprotective strategies in ischemic retinal lesions. [20386654] Int J Mol Sci 11(2):544-61 (2010) |
| 2009 21 | Unconventional neurotransmitters, neurodegeneration and neuroprotection. [19219299] Braz J Med Biol Res 42(1):68-75 (2009) |
| 2004 22 | The search for neuroprotective strategies in stroke. [14970016] AJNR Am J Neuroradiol 25(2):181-94 (2004) |
| 2010 23 | Mitochondrial mechanisms of estrogen neuroprotection. [19931595] Biochim Biophys Acta 1800(10):1113-20 (2010) |
| 2007 24 | Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. [17431228] Endocr Rev 28(4):387-439 (2007) |
| 2008 25 | Mitochondria, oxidative stress and PARP-1 network: a new target for neuroprotective effects of tetracyclines? [18372301] J Physiol 586(10):2427-8 (2008) |
| 2011 26 | Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs. [21606622] J Pharmacol Sci 116(2):137-48 (2011) |
| 2008 27 | Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects. [18198471] J Pharmacol Sci 106(1):22-7 (2008) |
| 2010 28 | The endocannabinoid system as a target for the treatment of neurodegenerative disease. [20590559] Br J Pharmacol 160(3):480-98 (2010) |
| 2010 29 | Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection. [20128800] Br J Pharmacol 159(3):495-501 (2010) |
| 2009 30 | IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions. [19438508] Br J Pharmacol 157(6):881-91 (2009) |
| 2008 31 | Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. [18059324] Br J Pharmacol 153 Suppl 1(-):S325-38 (2008) |
| 2006 32 | Endogenous neuroprotective factors: neurosteroids. [16845207] Pharmacol Rep 58(3):335-40 (2006) |
| 2011 33 | Role of vinpocetine in cerebrovascular diseases. [21857073] Pharmacol Rep 63(3):618-28 (2011) |
| 2005 34 | Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. [15985713] Pharmacol Rep 57(3):307-20 (2005) |
| 2011 35 | The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. [21340000] Int J Mol Sci 12(1):506-69 (2011) |
| 2008 36 | Estrogens and progesterone as neuroprotectants: what animal models teach us. [17981614] Front Biosci 13(-):1083-9 (2008) |
| 2011 37 | Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries. [21274503] Mol Med 17(5-6):448-56 (2011) |
| 2009 38 | The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. [18845187] Brain Res Rev 59(2):293-315 (2009) |
| 2008 39 | Progesterone exerts neuroprotective effects after brain injury. [17826842] Brain Res Rev 57(2):386-97 (2008) |
| 2008 40 | Drugs acting on SUR1 to treat CNS ischemia and trauma. [18032110] Curr Opin Pharmacol 8(1):42-9 (2008) |
| 2008 41 | Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases. [17945532] Curr Opin Pharmacol 8(1):25-32 (2008) |
| 2008 42 | Neuroglobin: an endogenous neuroprotectant. [17942367] Curr Opin Pharmacol 8(1):20-4 (2008) |
| 2007 43 | A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress. [17913843] Am J Physiol Cell Physiol 293(6):C1884-94 (2007) |
| 2010 44 | Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury. [20685313] Exp Neurol 225(1):104-13 (2010) |
| 2010 45 | Prospects for minocycline neuroprotection. [20697034] Arch Neurol 67(12):1442-8 (2010) |
| 2007 46 | Neuroprotection: challenges and opportunities. [17562927] Arch Neurol 64(6):794-800 (2007) |
| 2007 47 | Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors. [17965746] Br J Pharmacol 152(8):1301-11 (2007) |
| 2011 48 | A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. [20146558] J Neurotrauma 28(8):1545-88 (2011) |
| 2010 49 | Neurotoxins: free radical mechanisms and melatonin protection. [21358970] Curr Neuropharmacol 8(3):194-210 (2010) |
| 2008 50 | Clearing the brain's cobwebs: the role of autophagy in neuroprotection. [19305790] Curr Neuropharmacol 6(2):97-101 (2008) |
| 2010 51 | Resveratrol as a therapeutic agent for neurodegenerative diseases. [20306310] Mol Neurobiol 41(2-3):375-83 (2010) |
| 2010 52 | Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. [20157789] Mol Neurobiol 41(2-3):172-9 (2010) |
| 2011 53 | Neuroprotection by spice-derived nutraceuticals: you are what you eat! [21360003] Mol Neurobiol 44(2):142-59 (2011) |
| 2010 54 | P2Y2 nucleotide receptor-mediated responses in brain cells. [20387013] Mol Neurobiol 41(2-3):356-66 (2010) |
| 2009 55 | Multiple roles of HDAC inhibition in neurodegenerative conditions. [19775759] Trends Neurosci 32(11):591-601 (2009) |
| 2010 56 | Erythropoietin for infants with hypoxic-ischemic encephalopathy. [20090525] Curr Opin Pediatr 22(2):139-45 (2010) |
| 2008 57 | Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. [19145989] Rev Neurosci 19(4-5):341-61 (2008) |
| 2011 58 | Citicoline: pharmacological and clinical review, 2010 update. [21432836] Rev Neurol 52 Suppl 2(-):S1-S62 (2011) |
| 2011 59 | Magnesium sulphate for fetal neuroprotection. [21877014] Rev Bras Ginecol Obstet 33(6):265-70 (2011) |
| 2010 60 | Potential future neuroprotective therapies for neurodegenerative disorders and stroke. [20176298] Clin Geriatr Med 26(1):125-47 (2010) |
| 2009 61 | Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. [18696266] Neurocrit Care 10(1):103-15 (2009) |
| 2008 62 | Recent trends in erythropoietin-mediated neuroprotection. [17936539] Int J Dev Neurosci 26(1):103-11 (2008) |
| 2008 63 | Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. [18396368] Prog Neurobiol 85(2):194-213 (2008) |
| 2011 64 | Proinsulin: from hormonal precursor to neuroprotective factor. [21949502] Front Mol Neurosci 4(-):20 (2011) |
| 2009 65 | Neuroprotective actions of androgens on motoneurons. [19393684] Front Neuroendocrinol 30(2):130-41 (2009) |
| 2010 66 | Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. [20831615] J Neurochem 115(4):806-13 (2010) |
| 2010 67 | Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review. [20964688] J Neurochem 115(4):845-53 (2010) |
| 2007 68 | In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked? [17572175] Biol Psychiatry 62(1):4-6 (2007) |
| 2011 69 | GDNF and protection of adult central catecholaminergic neurons. [21357726] J Mol Endocrinol 46(3):R83-92 (2011) |
| 2011 70 | Selective estrogen receptor modulators as brain therapeutic agents. [21071476] J Mol Endocrinol 46(1):R1-9 (2011) |
| 2010 71 | Complement in neuroprotection and neurodegeneration. [20116331] Trends Mol Med 16(2):69-76 (2010) |
| 2009 72 | HSP27: mechanisms of cellular protection against neuronal injury. [19860665] Curr Mol Med 9(7):863-72 (2009) |
| 2010 73 | Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality. [19527737] Life Sci 86(15-16):615-23 (2010) |
| 2007 74 | Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. [17379265] Steroids 72(5):381-405 (2007) |
| 2010 75 | Docosahexaenoic acid neurolipidomics. [19804838] Prostaglandins Other Lipid Mediat 91(3-4):85-9 (2010) |
| 2009 76 | Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. [19137430] Apoptosis 14(4):469-77 (2009) |
| 2010 77 | Control of intracellular calcium signaling as a neuroprotective strategy. [20335972] Molecules 15(3):1168-95 (2010) |
Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth
All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.